SCHOLAR ROCK HOLDING CORPORATION Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property
SCHOLAR ROCK HOLDING CORPORATION (SRRK) reported Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property of -$3.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets · last filed 2026-08-06
- SCHOLAR ROCK HOLDING CORPORATION gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2026-06-30 was $0.00.
- SCHOLAR ROCK HOLDING CORPORATION gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2026-03-31 was -$3.00K.
- SCHOLAR ROCK HOLDING CORPORATION gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2022-12-31 was -$1.00K.
- SCHOLAR ROCK HOLDING CORPORATION gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2022-09-30 was $0.00.
- SCHOLAR ROCK HOLDING CORPORATION gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2023 was -$11.00K.
- SCHOLAR ROCK HOLDING CORPORATION gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2022 was -$33.00K.
- SCHOLAR ROCK HOLDING CORPORATION gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2021 was -$24.00K.
- SCHOLAR ROCK HOLDING CORPORATION gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2020 was -$28.00K, a 450.00% decline from fiscal 2019.
| Period end | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 3 month | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 6 month | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 9 month | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$3.00K 10-Q · filed 2026-08-06 | ||
| 2026-03-31 | -$3.00K 10-Q · filed 2026-05-07 | |||
| 2025-06-30 | $0.00 10-Q · filed 2026-08-06 | |||
| 2023-12-31 | -$11.00K 10-K · filed 2025-02-27 | |||
| 2022-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | -$1.00K derived: sum of 2 quarters · filed 2024-03-19 | -$33.00K 10-K · filed 2024-03-19 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$32.00K 10-Q · filed 2023-11-07 | ||
| 2022-06-30 | -$32.00K 10-Q · filed 2023-08-09 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | $0.00 derived: sum of 2 quarters · filed 2023-03-07 | $0.00 derived: sum of 3 quarters · filed 2023-03-07 | -$24.00K 10-K · filed 2023-03-07 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2022-11-14 | -$24.00K 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$24.00K 10-Q · filed 2022-08-08 | ||
| 2021-03-31 | -$24.00K 10-Q · filed 2022-05-16 | |||
| 2020-12-31 | -$28.00K 10-K · filed 2022-03-07 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | $8.00K 10-K · filed 2021-03-09 | ||
| 2019-09-30 | $8.00K 10-Q · filed 2020-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |